DREAMM-6: Safety and tolerability of belantamab mafodotin in combination with bortezomib/dexamethasone in relapsed/refractory multiple myeloma (RRMM).
暂无分享，去创建一个
A. Nooka | A. Khot | M. Mateos | R. Abonour | G. Ferron-Brady | Bikramjit Chopra | R. Popat | K. Stockerl-Goldstein | A. Yeakey | K. Luptakova | H. Quach | I. Gupta | M. Talekar | A. Tan | Rachel Rogers | A. Forbes | J. Davidge | Steve Frey | B. Chopra | R. Rogers | Geraldine Ferron-Brady